Toshiba trims ultrasound product line in U.S.

Article

Toshiba America Medical Systems has sharply focused its U.S. ultrasoundproduct efforts. The vendor has ended the sales of scanners intosuch markets as ob/gyn and urology--which were channeled throughdealers--in order to focus its own direct sales efforts

Toshiba America Medical Systems has sharply focused its U.S. ultrasoundproduct efforts. The vendor has ended the sales of scanners intosuch markets as ob/gyn and urology--which were channeled throughdealers--in order to focus its own direct sales efforts on radiologyand cardiology, according to Daniel Dugan, vice president forultrasound business operations.

"We cover the (U.S.) market with dedicated ultrasoundpeople and no distributors," Dugan told SCAN.

Trimming its product line will help TAMS avoid customer confusionabout what scanners are meant for which markets. The strategywill also let the vendor concentrate ultrasound advertising, marketingand sales resources on the two dominant user groups in this market,he said.

"We may come back to the ob/gyn market, for instance,but with a product designed and built for the U.S. market anda dedicated organization set up to sell it," Dugan said.

TAMS has expanded its ultrasound sales and service staff tofocus on these two large market segments. Although some short-termrevenue was sacrificed by the shift of products, overall ultrasoundrevenue will have grown 45% to 50% in fiscal 1991 (end-March).This makes TAMS the fastest growing ultrasound company in theU.S., he said.

Toshiba is readying the seventh software revision for its 270high-end ultrasound scanner, which should be available by May.A unique feature of the upgrade is independent beam steering forgray-scale imaging, spectral Doppler and color-flow Doppler, saidThomas Jedrzejewicz, director of marketing.

Gray-scale imaging is optimized when the beam runs perpendicularto the vessel. However, vessels do not always run parallel tothe skin, he noted. Color-flow Doppler, on the other hand, requiresits own approach to the vessel for optimization of the flow velocitymap.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.